Injectable Drug Compatibility News

In this update we added a new monograph for NUTRILIPID. We also added new stability information to the monographs for FAT EMULSION, NUTRILIPID, NOREPINEPHRINE BITARTRATE and TRACE ELEMENT SOLUTION. New compatibility information was added to the existing drug monographs for FAT EMULSION with 36 different drugs; INTRALIPID, NUTRILIPID, and SMOFLIPID, each with 17 different drugs; TOTAL PARENTERAL NUTRITION SOLUTIONS, TRACE ELEMENT SOLUTION, and VALPROATE SODIUM.

In this update we added new monographs for MOGAMULIZUMAB-KPKC and REMIMAZOLAM BESYLATE. We also added new stability information to the monographs for ASPARAGINASE, BEVACIZUMAB, DEXCHLORPHENIRAMINE MALEATE, FERRIC CARBOXYMALTOSE, IDARUBICIN HYDROCHLORIDE, ISOPROTERENOL HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE, VASOPRESSIN, and VORICONAZOLE. New compatibility information was added to the existing drug monographs for CALCIUM CHLORIDE, DEFIBROTIDE SODIUM, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, REMIFENTANIL HYDROCHLORIDE, and REMIMAZOLAM BESYLATE with six other drugs.

Spring 2023 In this update we added a new monograph for LACOSAMIDE. We also added new stability information to the monographs for ASCORBIC ACID, CONJUGATED ESTROGENS, LEVOLEUCOVORIN CALCIUM, SODIUM BICARBONATE, and THIAMINE HYDROCHLORIDE. New compatibility information was added to the existing drug monographs for CYTARABINE, DEXAMETHASONE SODIUM PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE SODIUM SUCCINATE, ONDANSETRON HYDROCHLORIDE, and DEXMEDETOMIDINE with twenty-three other drugs.

Winter 2022 In this update we added a new monograph for TOCILIZUMAB. We also added new stability information to the monographs for DIGOXIN, HYDROMORPHONE HYDROCHLORIDE, MORPHINE HYDROCHLORIDE, SODIUM CHLORIDE, and VANCOMYCIN HYDROCHLORIDE. New compatibility information was added to the existing drug monograph for AMPHOTERICIN B, BUMETANIDE, FOSFOMYCIN DISODIUM, PLAZOMICIN, SCOPOLAMINE HYDROBROMIDE, and IMIPENEM, CILASTATIN AND RELEBACTAM with 28 other drugs.

In this update we added a new monograph for MARGETUXIMAB-CMKB and METHYLPHENIDATE HYDROCHLORIDE. We also added new stability information to the monographs for CEFTOLOZANE AND TAZOBACTAM, CEFUROXIME SODIUM, FILGRASTIM, INSULIN ASPART, INSULIN GLULISINE, INSULIN LISPRO, LEVETIRACETAM, PIPERACILLIN AND TAZOBACTAM, and VANCOMYCIN HYDROCHLORIDE. New compatibility information was added to the existing drug monograph for IMIPENEM, CILASTATIN, and RELEBACTAM with 52 other drugs.